Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Docetaxel-PM in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
KCT0003480Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Feb 2016
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of Nanoxel M in head and neck squamous cell carcinoma (HNSCC), sponsored by Asan Medical Center. Started Feb 2016; status: completed.
02
Drugs
Nanoxel M
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on KCT0003480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003480.